HomeSMMT • NASDAQ
Summit Therapeutics Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 66.85M | 57.71% |
Net income | -62.91M | -44.72% |
Net profit margin | — | — |
Earnings per share | -0.07 | -41.37% |
EBITDA | -66.83M | -57.75% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 361.32M | 130.61% |
Total assets | 383.82M | 117.12% |
Total liabilities | 39.49M | -70.21% |
Total equity | 344.33M | — |
Shares outstanding | 742.67M | — |
Price to book | 50.20 | — |
Return on assets | -40.79% | — |
Return on capital | -44.76% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -62.91M | -44.72% |
Cash from operations | -61.17M | -102.99% |
Cash from investing | 160.11M | 705.75% |
Cash from financing | 7.68M | 1,482.89% |
Net change in cash | 106.66M | 1,186.78% |
Free cash flow | -35.75M | -79.77% |
Previous close
$23.09
Day range
$23.07 - $23.74
Year range
$2.10 - $36.91
Market cap
17.15B USD
Avg Volume
5.64M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2003
Website
Employees
159
